Company: CORT
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001628280-25-008167
Chunk: 77

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-02-26
Form: 10-K
Item: Item 9B
Chunk 77
---
ITEM 9B.  OTHER INFORMATION

Insider Trading Arrangements

During the quarter ended December 31, 2024, none of directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated any contract, instruction or written plan for the purchase or sales of our securities that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, or any “non-Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K, other than as set forth in the table below.NamePositionActionAdoption DateTotal Shares of Common Stock to be SoldExpiration Date(1)Joseph K. Belanoff, M.D.Chief Executive OfficerAdoption11/26/2024Up to 400,0008/31/2026William GuyerChief Development OfficerAdoption11/27/2024Up to 360,0008/31/2026(1) Each trading arrangement permits transactions through and including the earlier to occur of (a) the completion of all sales or (b) the date listed in the table.